
    
      RP3 is a genetically modified herpes simplex type 1 virus (HSV-1) that expresses exogenous
      genes (anti-CTLA-4 antibody, CD40 ligand and h4-1BBL) designed to directly destroy tumors and
      generate an anti-tumor immune response
    
  